Serious Infections in Offspring Exposed in Utero to Vedolizumab.
Sign Up to like & getrecommendations! Published in 2023 at "Inflammatory bowel diseases"
DOI: 10.1093/ibd/izad079
Abstract: Controlling IBD during pregnancy is important for maternal and fetal outcomes. We created a cohort of children born to mothers with IBD, comparing the risk of infections in those exposed to vedolizumab vs unexposed. We… read more here.
Keywords: utero vedolizumab; infections offspring; offspring exposed; serious infections ... See more keywords
POS1420 RISK OF SERIOUS INFECTIONS IN OFFSPRING EXPOSED IN UTERO TO USTEKINUMAB OR VEDOLIZUMAB
Sign Up to like & getrecommendations! Published in 2021 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2021-eular.691
Abstract: Ustekinumab, an IL-12/23 inhibitor, is indicated in adult patients with inflammatory bowel disease (IBD), psoriasis (PsO), and psoriatic arthritis (PsA) and vedolizumab, an α4β7 receptor antagonist is indicated in IBD only. Both are monoclonal antibodies… read more here.
Keywords: offspring exposed; vedolizumab; risk; ustekinumab vedolizumab ... See more keywords